Oct 11, 2022
New Survey Focused on Access Limitations of Approved Autologous CAR T Therapies Reveals Only 50% of Eligible Cancer Patients Receive Treatment Increased Patient Demand , Manufacturing Capacity and Time to Treatment Highlighted as the Top Three Challenges Facing Future CAR T Adoption Initiative Aims
Displaying 1 - 10 of 33